S. 154 — Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021

“A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.”